Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous‐cell carcinoma

Nazia Syed(Pondicherry University), Harsha Gowda(Yenepoya University)

PROTEOMICS

November 4, 2014

10.1002/pmic.201400379

Cited by 23

Related Papers

MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma

|Scientific Reports|2019|21

Temporal Quantitative Proteomics Reveals Proteomic and Phosphoproteomic Alterations Associated with Adaptive Response to Hypoxia in Melanoma Cells

|Cancers|2021|9

Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays

|Oncotarget|2018|5